Skip to content

Humana HUM Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

CVS Health logo
CVS HealthCVS
UnitedHealth Group logo
UnitedHealth GroupUNH
HCA Healthcare logo
HCA HealthcareHCA
Alignment Healthcare logo
Alignment HealthcareALHC
InnovAge Holdings, Inc. logo
InnovAge Holdings, Inc.INNV
Hitachi logo
HitachiHIT

Other financials

Income statement

See full
Revenue$39.6B+23.5%
Operating income$1.8B-12.9%
Net income$1.2B-4.7%
EPS (diluted)$9.83-4.6%

Balance sheet

See full
Cash & equivalents$5.0B+16.5%
Total debt$14.0B+5.2%
Total equity$18.6B+4.7%
Total assets$55.3B+8.5%

Cash flow

See full
Operating cash flow$1.3B+279%
CapEx$121.0M+27.4%
Free cash flow$1.1B+380%

Valuation

See full
Market cap$47.69B+64.5%
Enterprise value$56.73B+51.1%
P/E15×-1.9×
P/S0.4×+0.1×

Profitability

See full
Operating margin2.7%-1.7pp
Net margin3%-0.1pp
FCF margin4.2%

Returns & leverage

See full
Return on equity18.2%+0.9pp
Debt / equity0.8×0.0×
Current ratio1.8×-0.1×

Where this comes from

Reported directly by Humana in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Humana’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Humana's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Humana's common stock, shares authorized (in shares)?
Humana (HUM) reported common stock, shares authorized (in shares) of $300M in Q1 2026.
How has Humana's common stock, shares authorized (in shares) changed year-over-year?
Humana's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $300M to $300M.
What is the long-term trend for Humana's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Humana's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $300M to $300M.